Name
EXECUTIVE PANEL: Exploring the hurdles that are in place whilst targeting solid tumors; and how to clear the route for an “off the shelf” therapy
Date & Time
Tuesday, July 7, 2020, 9:05 AM - 9:45 AM
Speakers
Nick Cernese - EY
Peter Emtage - Kite Pharma Inc
Pascal Touchon - Atara Biotherapeutics
Stefan Wildt - Takeda Pharmaceuticals
Peter Emtage - Kite Pharma Inc
Pascal Touchon - Atara Biotherapeutics
Stefan Wildt - Takeda Pharmaceuticals




Session Type
Panel
Virtual Session Link